Gut Microbiota Modulation: Probiotics, Postbiotics and other Bioactive Compounds
A special issue of Pharmaceuticals (ISSN 1424-8247). This special issue belongs to the section "Natural Products".
Deadline for manuscript submissions: 25 September 2024 | Viewed by 18585
Special Issue Editors
Interests: gut microbiota; immune system; nutrition respiratory health
Interests: Research on the field of food and nutrition, including the effect of natural food probiotics on gut health and homeostasis, antimicrobial properties of natural products, and new sustainable technologies for food conservation
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
In recent years, gut microbiota has been intensively explored at various levels. With the advent of multi-omics techniques such as metagenomics and metatranscriptomics, the structure and function of the microbiota have begun to be understood. Given that 70–80% of immune cells are found in the gut, it is clear what a major impact this “super organ” has on health.
Strategies to promote a “good” microbial community turn out to be crucial for a fine-tuned symbiotic relationship with the host, contributing to the prevention of disease occurrence and to the management of diseases that are usually correlated with dysbiosis states, as already observed in metabolic and respiratory disorders, among others.
Probiotics can be cost-effective in preventing and managing some diseases; however, it is usually very difficult to provide experimental evidence for health claims on probiotics as there are many variables to consider, such as specific species, strain, dose or duration of treatment, and host individual responses. There is still uncertainty about whether living probiotic strains are able to colonize and function in the human tract as some people appear to be more resistant to colonization.
Alternatively, the use of standardized doses of certain purified inactivated microbial cells or cell components, microbial metabolites and bioactive compounds generated by fermentation/enzyme hydrolyses, administered alone, have been recently suggested to modulate the gut microbiota and impact host health and disease.
Topics to be covered within this Special Issue include (but are not limited to):
- Novel probiotic strains;
- Influence of probiotics and/or bioactive compounds on gut microbiota modulation;
- Influence of probiotics and/or bioactive compounds in health and disease states;
- Signaling pathways mediating probiotics-host effects;
- Safety and regulations for the use of probiotics;
- Bioactive compounds able to modulate the gut microbiota and generated by fermentation/enzyme hydrolyses or food processing methods.
Contributions of original research to review articles are welcome.
Dr. Inês Brandão
Dr. Christophe Ruis Espírito Santo
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceuticals is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- gut microbiota
- bioactive compounds
- immune system
- nutrition respiratory health
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
